Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported OutcomesJessie L. Barnum, Paul Szabolcs, Kathryn S. Torok et al.|Blood|2022Cited by 2